Your browser doesn't support javascript.
loading
Crizotinib treatment for refractory pediatric acute myeloid leukemia with RAN-binding protein 2-anaplastic lymphoma kinase fusion gene.
Hayashi, A; Tanoshima, R; Tsujimoto, S-I; Yanagimachi, M; Takeuchi, M; Sasaki, K; Ikeda, J; Kajiwara, R; Ito, S; Takahashi, H.
Afiliación
  • Hayashi A; Department of Pediatrics, Yokohama City University, Yokohama, Japan.
  • Tanoshima R; Department of Pediatrics, Yokohama City University, Yokohama, Japan.
  • Tsujimoto SI; Department of Pediatrics, Yokohama City University, Yokohama, Japan.
  • Yanagimachi M; Department of Pediatrics, Yokohama City University, Yokohama, Japan.
  • Takeuchi M; Department of Pediatrics, Yokohama City University, Yokohama, Japan.
  • Sasaki K; Department of Pediatrics, Yokohama City University, Yokohama, Japan.
  • Ikeda J; Department of Pediatrics, Yokohama City University, Yokohama, Japan.
  • Kajiwara R; Department of Pediatrics, Yokohama City University, Yokohama, Japan.
  • Ito S; Department of Pediatrics, Yokohama City University, Yokohama, Japan.
  • Takahashi H; Department of Pediatrics, Toho University School of Medicine, Tokyo, Japan.
Blood Cancer J ; 6(8): e456, 2016 08 05.
Article en En | MEDLINE | ID: mdl-27494825
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Piridinas / Leucemia Mieloide Aguda / Proteínas de Fusión Oncogénica / Resistencia a Antineoplásicos Límite: Child, preschool / Female / Humans Idioma: En Revista: Blood Cancer J Año: 2016 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Piridinas / Leucemia Mieloide Aguda / Proteínas de Fusión Oncogénica / Resistencia a Antineoplásicos Límite: Child, preschool / Female / Humans Idioma: En Revista: Blood Cancer J Año: 2016 Tipo del documento: Article País de afiliación: Japón